Objectives:

- Share the latest news from ESMO-GI about real world clinical outcomes of >550 HCC patients treated with DEM-TACE

- Discuss the impact of big data from liver directed therapies to the multidisciplinary tumour board decision making process

- Explore DEM-TACE current practice and performance in various subsets of patients
  • 1599665866-5390a9cc8a90d6ed
    Prof. T. de Baère